CATALOGO DEI PRODOTTI DELLA RICERCA

ROSSINI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 13.905
NA - Nord America 13.346
AS - Asia 5.973
SA - Sud America 117
AF - Africa 66
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 15
Totale 33.448
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.287
GB - Regno Unito 5.134
CN - Cina 3.553
SG - Singapore 1.879
IT - Italia 1.733
RU - Federazione Russa 1.256
FR - Francia 1.161
DE - Germania 1.075
SE - Svezia 1.071
IE - Irlanda 1.043
FI - Finlandia 786
UA - Ucraina 274
TR - Turchia 143
JP - Giappone 110
NL - Olanda 83
BE - Belgio 72
BR - Brasile 71
VN - Vietnam 68
CA - Canada 49
TG - Togo 42
ES - Italia 40
KR - Corea 39
RO - Romania 37
IN - India 34
AT - Austria 30
IR - Iran 29
HK - Hong Kong 27
ID - Indonesia 27
AU - Australia 22
CL - Cile 16
CH - Svizzera 14
ZA - Sudafrica 12
PL - Polonia 11
PT - Portogallo 11
AR - Argentina 8
CZ - Repubblica Ceca 8
EC - Ecuador 8
EU - Europa 8
GR - Grecia 8
MX - Messico 8
SK - Slovacchia (Repubblica Slovacca) 8
BG - Bulgaria 7
HR - Croazia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
IL - Israele 6
IQ - Iraq 6
BD - Bangladesh 5
DK - Danimarca 5
MA - Marocco 5
QA - Qatar 5
CO - Colombia 4
EG - Egitto 4
LK - Sri Lanka 4
LV - Lettonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
EE - Estonia 3
HU - Ungheria 3
KW - Kuwait 3
LT - Lituania 3
MK - Macedonia 3
MY - Malesia 3
PE - Perù 3
PH - Filippine 3
SI - Slovenia 3
TH - Thailandia 3
UZ - Uzbekistan 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
IS - Islanda 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MN - Mongolia 2
PK - Pakistan 2
RS - Serbia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CU - Cuba 1
CY - Cipro 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
IM - Isola di Man 1
JO - Giordania 1
NG - Nigeria 1
PA - Panama 1
PY - Paraguay 1
SC - Seychelles 1
SM - San Marino 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
Totale 33.448
Salva come PNG Salva come JPEG
Città #
Southend 4.797
Jacksonville 2.246
Chandler 2.205
Singapore 1.504
Woodbridge 1.244
Dublin 1.027
Ann Arbor 959
Ashburn 698
Houston 671
Beijing 533
Lawrence 448
Princeton 448
Wilmington 424
Jinan 327
Nanjing 296
Shenyang 279
New York 248
Redmond 238
Verona 222
Bologna 203
Helsinki 196
Sindelfingen 179
Hebei 175
Milan 161
Tianjin 146
Changsha 133
Ningbo 113
Haikou 110
Nanchang 107
Boardman 106
Zhengzhou 106
Tokyo 95
Jiaxing 88
Hangzhou 84
Taizhou 83
Redwood City 72
Guangzhou 68
Seattle 68
Taiyuan 68
Brussels 65
Norwalk 65
Santa Clara 57
Los Angeles 56
Rome 56
Washington 56
Falls Church 51
Moscow 50
Fairfield 48
Lanzhou 44
Fuzhou 43
Dearborn 42
Lomé 42
Dallas 41
Dong Ket 41
Orani 40
San Francisco 39
Chicago 32
Düsseldorf 31
Seoul 27
Vienna 27
Toronto 26
Amsterdam 25
Dongguan 25
Groningen 25
Cagliari 24
Detroit 24
Jakarta 24
Lancaster 22
Sanayi 20
Frankfurt am Main 19
Kent 18
London 18
Nürnberg 18
Venice 18
Lappeenranta 17
Esslingen am Neckar 16
Menlo Park 16
Paris 16
Torino 16
Shanghai 14
Hong Kong 13
Leawood 13
Munich 13
Padova 13
Phoenix 12
Auburn Hills 11
Cambridge 11
Romola 11
São Paulo 11
Bolzano 10
Boydton 10
Falkenstein 10
Kemerovo 10
San Diego 10
Tappahannock 10
Turin 10
Bari 9
Brescia 9
Clearwater 9
Madrid 9
Totale 22.743
Salva come PNG Salva come JPEG
Nome #
Fibromialgia. Razionale e risultati del trattamento con L-Acetilcarnitina. 374
Epidemiology and Economic Burden of Osteoporosis in Italy 311
Teriparatide and denosumab combination therapy and skeletal metabolism 249
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 225
La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica. 179
Artrite Reumatoide e Metabolismo Minerale 174
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 150
Association of CTR and COLIA1 alleles with BMD values in peri and postmenopausal women 146
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 145
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 142
Acute Phase Response After Zoledronic Acid is Associated with Long-Term Effects on White Blood Cells. 140
The genetic background of osteoporosis in cystic fibrosis: association analysis with polymorphic markers in four candidate genes 138
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 137
Incidenza di ipovitaminosi D nel Nord Italia 136
[The long term correction of vitamin D deficiency: comparison between different treatments with vitamin D in clinical practice.]. 135
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 133
[Therapeutic strategies in osteoporosis: whom and when to treat] 125
[Diphosphonates: and alternative to estrogen therapy in postmenopausal osteoporosis. Experience with alendronate] 124
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 123
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 122
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 122
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 121
Age-related bone loss in postmenopausal women 120
Rapporti tra sistema immune e metabolismo osseo 120
Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis 120
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 120
CD14(++) CD16(-) monocytes are the main source of 11β-HSD type 1 after IL-4 stimulation 119
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 119
Bone metabolism in patients with anorexia nervosa and amenorrhoea 117
DXA bone mineral density in males: retrospective study in real life. 116
Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases 116
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 116
Prevalence and incidence of rheumatoid arthritis in Italy. 116
Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis 116
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 115
New strategies for the prevention and treatment of systemic and local bone loss; from pathophysiology to clinical application 114
Concentric left ventricular remodelling is associated with subclinical systolic dysfunction in patients with psoriatic arthritis 114
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 112
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 111
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 110
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 109
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 108
Osteoporosis treatment: why ibandronic acid? 107
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case Series 107
The renal handling of calcium: influence of parathyroid hormone secretion 106
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 106
Guidelines for the diagnosis, prevention and management of osteoporosis 106
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 105
Osteopetrosi 104
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 104
Anti-CCP antibodies and bone 104
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 103
Clinical profile and outcome of patients with rheumatoid arthritis and abnormally high aortic stiffness 103
Vitamin D levels in patients with psoriasis with or without arthritis 102
Prevalence of osteoporosis in patients affected by mastocytosis 102
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 102
Rituximab increases peripheral natural killer cells in patients with rheumatoid arthritis 102
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 102
Anabolic steroids in corticosteroid-induced osteoporosis 101
Incidenza di ipovitaminosi D nel Nord Italia 101
Intermittent etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH Agonist. 101
Safety issues and adverse reactions with osteoporosis management 100
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 100
Osteoporosi: progressi nella diagnosi e nel trattamento 99
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 99
[Study of vitamin D status of rheumatoid arthritis patients. Rationale and design of a cross-sectional study by the osteoporosis and metabolic bone diseases study group of the Italian Society of Rheumatology (SIR)]. 98
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 98
Could γ\δ T-cells explain zoledronic acid adverse events? 98
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 98
Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis. 97
The initiative on hip fractures of the Veneto Region 97
Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study 97
Bone involvement and osteoporosis in mastocytosis. 96
Bone turnover markers in patients with osteogenesis imperfecta 95
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 95
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 95
Bone involvement in patient with clonal mast cell disorders 95
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 95
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 94
Bone turnover markers in patients with osteogenesis imperfecta. 94
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 93
[Risk factors for hip fracture in elderly persons]. 93
Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes 93
Systemic mastocytosis: a muldisciplinary approach (Review) [Lamastocitosi sistemica: Un approccio multidiscliplinare] 92
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 92
Duration of treatment for osteoporosis 92
The radiological assessment of vertebral osteoporosis 91
Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. 91
Sclerostin and DKK1 in primary hyperparathyroidism. 91
Drug-induced osteonecrosis of the jaw: the state of the art 91
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 91
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 91
Peak bone mass and peak bone density. 91
Effects of denosumab on peripheral lymphocyte subpopulations 91
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 90
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 90
Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease 90
The appendicular bone measurements. 90
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 89
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 89
Totale 11.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.544
article - articoli 122.884
book - libri 0
conference - conferenze 1.893
curatela - curatele 0
other - altro 274
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.493
Totale 257.088
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.860 0 0 0 0 0 0 359 369 198 321 139 474
2020/20213.886 427 729 113 436 497 426 82 243 307 27 441 158
2021/20223.278 240 811 49 158 156 128 61 185 279 97 305 809
2022/20236.844 562 555 704 1.182 607 1.654 87 384 733 75 226 75
2023/20243.519 179 270 330 419 404 534 181 274 58 128 496 246
2024/20253.866 564 680 406 1.477 473 257 9 0 0 0 0 0
Totale 34.168